Sign In
Buy IUGNF
$0.0600
+0 (+0%)
At Close: Jun 03, 2026
Dow Jones, Nasdaq close at record levels as Trump says US-Iran peace talks are advancing
12:15pm, Monday, 01'st Jun 2026
4:15pm: Peace optimism boosts stocks US stocks finished Monday’s session higher on renewed hopes a peace deal would be struck between the US and Iran, with...
Costco's value strategy, membership growth support outlook after strong quarter, says Jefferies
12:08pm, Monday, 01'st Jun 2026
Costco Wholesale Corporation (NASDAQ:COST, XETRA:CTO) delivered a strong fiscal third quarter performance, with its value-focused strategy, membership...
Anthropic confidentially files to go public in the US
09:12am, Monday, 01'st Jun 2026
Anthropic said on Monday it has confidentially filed for a US initial public offering, positioning the artificial intelligence company for what could become...
Iovance Biotherapeutics pushes cell therapy platform into solid tumor market
08:29am, Monday, 01'st Jun 2026
Iovance Biotherapeutics (NASDAQ:IOVA) said it has obtained clearance of an Investigational New Drug application for IOV-5001, extending its next-generation...
Small Cap Watch: commercial expansion updates drive news flow
06:02am, Monday, 01'st Jun 2026
The S&P/ASX Small Ordinaries Index continued its strong run, climbing 2.28% on Friday to close at 3,501.80 and gaining 2.19% over the past five trading...
Imugene presents azer-cel data at ASCO as trial expands into new cohort
05:50am, Monday, 01'st Jun 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has presented new Phase 1b data for its azer-cel cell therapy at the 2026 American Society of Clinical Oncology...
Imugene targets blood cancer with off-the-shelf CAR-T - ICYMI
06:50am, Friday, 29'th May 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) recently highlighted encouraging new clinical data for its allogeneic CAR-T therapy Azer-Cel, while also...
Costco reports strong sales growth in fiscal third quarter
12:41pm, Thursday, 28'th May 2026
Costco Wholesale Corporation (NASDAQ:COST, XETRA:CTO) reported fiscal third quarter financial results that topped Wall Street expectations, though shares...
Imugene doses first patient in BTKi combination cohort for azer-cel study
07:14am, Thursday, 28'th May 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has dosed the first patient in the Bruton Tyrosine Kinase inhibitor (BTKi) combination cohort of its Phase 1b...
Imugene strengthens board with biotech and pharma appointments
07:29am, Tuesday, 26'th May 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has appointed Dr Charmaine Gittleson and Michael Kotsanis as non-executive directors as part of a board...
IBM shares extend rally as Wedbush calls US quantum investment a "new catalyst"
08:20am, Friday, 22'nd May 2026
International Business Machines Corp (NYSE:IBM) shares are on track to close the week nearly 18% higher after the US Department of Commerce's $2 billion...
Diamond Equity Research Releases Update Note on Imugene Limited (ASX: IMU)
08:00am, Wednesday, 20'th May 2026
New York, May 20, 2026 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an update note on Imugene Ltd. (ASX: IMU)
Imugene valuation points to 129% upside as broker backs azer-cel strategy
08:18am, Wednesday, 13'th May 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) could be significantly undervalued as its focused push into allogeneic CAR-T therapy gathers momentum, according...
Apple reports record March quarter revenue on strong iPhone sales
12:51pm, Thursday, 30'th Apr 2026
Apple Inc (NASDAQ:AAPL, XETRA:APC) reported fiscal second quarter 2026 results that topped Wall Street expectations for both revenue and earnings. The...
Imugene secures shareholder backing, completes $16 million capital raising package
11:32am, Thursday, 23'rd Apr 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has secured overwhelming shareholder support for a series of funding-related resolutions at its extraordinary...
